Globus Medical (GMED)

Debt-to-equity ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 4,177,330 4,069,400 3,976,360 3,922,360 3,997,960 4,187,280 1,985,060 1,914,820 1,846,370 1,764,110 1,699,090 1,785,370 1,741,390 1,718,270 1,639,270 1,562,990 1,506,300 1,417,200 1,336,920 1,363,370
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $4,177,330K
= 0.00

Globus Medical's debt-to-equity ratio has consistently remained at 0.00 throughout the period from March 31, 2020, to December 31, 2024. A debt-to-equity ratio of 0.00 typically indicates that the company has no debt or a negligible amount of debt compared to its equity. This suggests that Globus Medical relies more on equity financing rather than debt financing to fund its operations and growth. Having a low or zero debt-to-equity ratio can demonstrate financial stability and a lower risk profile for the company, as it implies lower financial leverage and less exposure to interest rate risk. In the case of Globus Medical, the consistent 0.00 debt-to-equity ratio over the analyzed period may reflect a conservative financial strategy focused on maintaining a strong balance sheet and financial health.